How Recursion is leading a new era of AI-driven drug discovery AI drug discovery is not a new phenomenon – but it is evolving at an almost dizzying pace. Recursion is one of the earliest innovators in ...

Recursion Pharmaceuticals is trying to solve a serious problem. Even with technological improvements, the time and costs required to develop brand-new drugs have increased in recent decades. It can ...

Anthropic has warned that recursive-self-improving AI could be on the horizon, but the truth is the company is more ...

Recursion is building an industrialized engine for medicine. It operates among biotech stocks, selling access to its proprietary platform and pursuing joint development with major partners like Roche ...

Anthropic's internal data shows Claude writing most of its code, an early signal of recursive self-improvement in AI.

The maker of Claude wants AI labs, including itself, to prepare for a coordinated slowdown if models begin building their own ...

Artificial intelligence (AI) may not be building better versions of itself yet, but Anthropic says the world is moving closer to that possibility than many people realize. In a new research paper ...

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings.

Learning to program in C on an online platform can provide structured learning and a certification to show along with your resume. Learning C can still be useful in 2026, especially if you want to ...

Python’s lead narrows again, C holds the runner-up spot, C++ returns to third, and SQL climbs back above R in June’s top 10 rankings update. June’s TIOBE Index has the feel of a rematch month. The top ...

“I am extremely grateful to have had such as empowering mentor such as Dr. Chao during my time in the SMART Program. She allowed me freedom in my research based on my interests and adequately ...